Instrument Inactif

Autres langues Intersect ENT, Inc.

Actions

XENT

US46071F1030

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P Healthcare Equipment Select Industry Index	17/05/22
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P TMI Index	17/05/22
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from S&P Global BMI Index	17/05/22
INTERSECT ENT, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	13/05/22
Medtronic Completes Purchase Of US Medical Device Group Intersect ENT	13/05/22
Medtronic Completes Purchase of Intersect ENT	13/05/22
Intersect ENT, Inc.(NasdaqGM:XENT) dropped from NASDAQ Composite Index	13/05/22
Hemostasis, LLC acquired Fiagon AG Medical Technologies from Intersect ENT, Inc.	13/05/22
Medtronic plc completed the acquisition of Intersect ENT, Inc..	13/05/22
INTERSECT ENT, INC. : Other Events (form 8-K)	09/05/22
INTERSECT ENT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	04/05/22
Intersect ENT, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	04/05/22
INTERSECT ENT, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	18/04/22
Intersect ENT, Inc. Enters into Amendment No.1 to Facility Agreement	18/04/22
INTERSECT ENT, INC. : Other Events (form 8-K)	23/03/22
INTERSECT ENT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	08/03/22
Intersect ENT, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	08/03/22
Intersect ENT Reports Positive Data From Real-World Evidence Study of Propel Sinus Implants	25/01/22
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization	25/01/22
Intersect ENT®, Inc. Announces Positive Results of Observational	25/01/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Intersect ENT, Inc.

Actions

XENT

US46071F1030

Autres langues

Filtres